Sanofi Supplies New Malaria Drugs | Chemical & Engineering News
Volume 92 Issue 33 | p. 17 | Concentrates
Issue Date: August 18, 2014

Sanofi Supplies New Malaria Drugs

Department: Business
Keywords: malaria, active pharmaceutical ingredients, drug manufacturing
[+]Enlarge
Workers at Sanofi’s plant in Morocco.
Credit: Sanofi
Workers at Sanofi’s plant in Morocco
 
Workers at Sanofi’s plant in Morocco.
Credit: Sanofi

A Sanofi plant in Morocco has begun supplying African countries with antimalarial combination drugs made with a semisynthetic artemisinin derivative. Sanofi partnered with the health care organization PATH; the University of California, Berkeley; and biotech firm Amyris to scale up the artemisinin process. It’s considered a more reliable source of the active ingredient than extracting it from the sweet wormwood plant. Last year, Sanofi and PATH began making artemisinin at Sanofi’s Garessio site in Italy. Sanofi says it can produce 50 to 60 metric tons per year of semisynthetic artemisinin, or enough to meet one-third of the world’s needs.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment